基本信息
浏览量:303
职业迁徙
个人简介
At Children's Hospital, I work with a team of world-class clinicians and scientists dedicated to rapidly translating research about childhood cancers from the laboratory to the patient. We are one of the nation’s leaders in early phase clinical research that intently focuses on improving pediatric cancer cure rates and minimizing long-term side effects. We design studies to help benefit children who have refractory or relapsed diseases for which treatment options may be limited. As we make new discoveries, our goal is to bring them quickly to young patients. I also serve as chairman of the national Children’s Oncology Group Neuroblastoma Committee, a research consortium of more than 200 member institutions.
My own specialty is neuroblastoma, an often intractable cancer that starts in young nerve cells and can be extremely aggressive. I've been interested in this disease since before medical school, when I had the opportunity to work with noted scientists Drs. Audrey Evans and Britton Chance. I later became convinced that neuroblastoma is a genetic disease, and that we could make critical insights by discovering the genes that cause the cancer.
To learn more and make a difference as quickly as possible, I developed a laboratory and translational research program at Children's Hospital to help us focus on the genetic abnormalities in hereditary and sporadic neuroblastoma. We strive to be the world’s leading neuroblastoma research and treatment center as we work to exponentially increase our understanding of this cancer and its underlying biology. Our challenge is to impact clinical practice – an effort we approach with urgency and a large measure of recent success. In the past few years, our team at Children's Hospital has been able to identify the main genes associated with this cancer. As a result, we moved some of these discoveries toward new therapies, a number of which are now in clinical trials.
To help support our investigations, my colleagues and I have gathered the largest collection of pediatric neuroblastoma cases ever assembled. This allowed us to perform studies that led to the discovery of neuroblastoma genes and identify who is likely to get the disease. Dr. Yael Mosse and I, along with our colleagues at Children's Hospital, found that mutations of the ALK (anaplastic lymphoma kinase) oncogene explain most hereditary neuroblastomas. The gene is also mutated in cancer cells -- making it a therapeutic target for this malignancy. Trials of an ALK-attacking compound for neuroblastoma patients are currently underway.
Our neuroblastoma team has made enormous progress as we translate our basic and clinical research into improved therapies. Patients, their families and referring physicians may be confident that our outstanding clinicians and researchers provide the most comprehensive and cutting edge care possible for children with this difficult cancer.
研究兴趣
论文共 153 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
PEDIATRIC BLOOD & CANCERno. 4 (2024): e30887-e30887
Rawan Shraim, Patrick M. Schuerch,Anna Maria Giudice,Karina L. Conkrite,Amber K. Weiner, Alexander B. Radaoui,Brian Mooney,Raushan T. Kurmasheva,Peter J. Houghton,Gregg B. Morin,Yael B. Mosse,Poul H. Sorensen,
Cancer Researchno. 6_Supplement (2024): 1090-1090
Amber K. Weiner,Hemma Murali,Rawan Shraim,Karina L. Conkrite, Alexander B. Radaoui,Daniel Martı́nez,Brian Mooney,Sandra E. Spencer Miko,Gian Luca Negri,Alberto Delaidelli, Caitlyn de Jong,Yuankun Zhu,
Cancer Researchno. 7_Supplement (2023): 4515-4515
引用0浏览0引用
0
0
Michael P. Randall, Laura E. Egolf,Zalman Vaksman, Minu Samanta,Matthew Tsang,David Groff, J. Perry Evans,Jo Lynne Rokita, Mehdi Layeghifard, Adam Shlien,John M. Maris,Sharon J. Diskin,
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTEno. 1 (2023): 138-148
SCIENCE IMMUNOLOGYno. 90 (2023)
Amber K. Weiner,Hemma Murali,Rawan Shraim,Karina L. Conkrite, Alexander B. Radaoui,Daniel Martinez,Brian Mooney,Sandra E. Spencer Miko, Gian Negri,Alberto Delaidelli, Caitlyn de Jong,Yuankun Zhu,
CANCER RESEARCHno. 7 (2023)
引用0浏览0引用
0
0
Amy K Erbe, Mitch B Diccianni,Rajen Mody,Arlene Naranjo,Fan F Zhang,Jen Birstler,KyungMann Kim,Arika S Feils,Jung-Tung Hung,Wendy B London,Barry L Shulkin, Varsha Mathew,
Cancer Researchno. 12_Supplement (2022): 6051-6051
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn